OHMX.bio, Fujirebio Europe to Develop Clinical In Vitro Diagnostics Platform
The IVD-seq project brings together a unique and complementary partnership of clinical IVD expertise from Fujirebio Europe and third generation sequencing based-omics solutions from OHMX.bio to develop a best-in-class IVD solution that completely operates from Belgium.
(Picture: Deposit Photos )
1/1 Back to the Article